The estimated Net Worth of Steven Zelenkofske is at least $1.76 Million dollars as of 6 June 2018. Steven Zelenkofske owns over 23,929 units of uniQure N.V stock worth over $872,235 and over the last 7 years Steven sold QURE stock worth over $888,723.
Steven has made over 1 trades of the uniQure N.V stock since 2018, according to the Form 4 filled with the SEC. Most recently Steven sold 23,929 units of QURE stock worth $888,723 on 6 June 2018.
The largest trade Steven's ever made was selling 23,929 units of uniQure N.V stock on 6 June 2018 worth over $888,723. On average, Steven trades about 3,988 units every 0 days since 2017. As of 6 June 2018 Steven still owns at least 159,458 units of uniQure N.V stock.
You can see the complete history of Steven Zelenkofske stock trades at the bottom of the page.
Steven's mailing address filed with the SEC is C/O ACHILLION PHARMACEUTICALS, INC., 1777 SENTRY PARKWAY W, BLDG 14, STE 200, BLUE BELL, PA, 19422.
Over the last 8 years, insiders at uniQure N.V have traded over $35,572,573 worth of uniQure N.V stock. The most active insiders traders include Deventer Sander Van, Paula Soteropoulos, and William Lewis. On average, uniQure N.V executives and independent directors trade stock every 14 days with the average trade being worth of $37,634. The most recent stock trade was executed by Walid Abi Saab on 26 June 2024, trading 1,447 units of QURE stock currently worth $6,309.
uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
uniQure N.V executives and other stock owners filed with the SEC include: